EXELON CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.32 USD | -0.90% |
|
-0.61% | +3.96% |
| 23/04 | Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating | MT |
| 22/04 | Scotiabank Adjusts Exelon's Price Target to $37 From $39 | MT |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
- Analyst opinion has improved significantly over the past four months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- One of the major weak points of the company is its financial situation.
- With an enterprise value anticipated at 3.88 times the sales for the current fiscal year, the company turns out to be overvalued.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Electric Utilities
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +3.96% | 37.31B | B- | ||
| +8.64% | 136B | C+ | ||
| +4.41% | 80.06B | B- | ||
| -2.19% | 77.98B | B | ||
| +0.69% | 75.38B | B+ | ||
| -8.92% | 66.47B | B- | ||
| +61.15% | 59.36B | C | ||
| +4.97% | 44.9B | A- | ||
| +7.34% | 42.26B | A- | ||
| 0.00% | 41.65B | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EXC Stock
- Ratings Exelon Corporation
